Clinically, PC is screened by measuring the index of cancer antigen 19-9 (CA 19-9) [5] and the carcinoembryonic antigen (CEA) [6], together with noninvasive screening, including abdominal ultrasound imaging and abdominal computed tomography imaging. The gene discussed is CEACAM5; the disease is pachyonychia congenita.